Garelius HKG, Bagguley T, Taylor A, Fenaux P, Bowen D, Symeonidis A, Mittelmann M, Stauder R, Čermák J, Sanz G, Langemeijer S, Malcovati L, Germing U, Sanhes L, d'Aveni M, Culligan D, Kotsianidis I, Koinig KA, van Marrewijk C, Crouch S, deWitte T, Smith A
Primary Author:
Garelius HKG
Journal Title:
Lancet Haematology
Original Publication Date:
Feb 2025
Background: In our previous study on erythropoiesis-stimulating agent (ESA) treatment in lower risk